Is Eli Lilly a Stock for the Long Term? (LLY, MRK, NVS, PFE)

Is Eli Lilly a Stock for the Long Term? (LLY, MRK, NVS, PFE)

A great look at a Big Pharma leader.

Company	Current P/E	Dividend Yield	5-Year Net Income CAGR	1-Year Beta
Eli Lilly	7.6	5.7%	20.7%	0.5
Pfizer (NYSE: PFE)	18.9	4.2%	0.4%	0.6
Merck (NYSE:MRK)	119.7	4.6%	(28.6%)	0.5
Novartis (NYSE:NVS)	13.6	4.2%	9.82%	0.3